hydrocortisone topical
Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
---|---|---|---|---|---|---|---|---|---|---|---|---|
CREAM WITH APPLICATOR, RECTAL | 2.50% | |||||||||||
CREAM, TOPICAL | 0.5%; 1%; 2.5%; valerate 0.2% | |||||||||||
FOAM WITH APPLICATOR, RECTAL | 10% | |||||||||||
LOTION, TOPICAL | 1%; 2.5% | |||||||||||
OINTMENT, TOPICAL | 0.50%; 1%; 2.5%; butyrate 0.1%; valerate 0.2% | |||||||||||
SPRAY, TOPICAL | 1% | Spray is Non Formulary | ||||||||||
SUPPOSITORY, RECTAL | 25 mg | |||||||||||
SUSPENSION, RECTAL | 100 mg/60 mL |
Medications Approved for Automatic Therapeutic Interchange Dosage Conversion Guidelines
(Note: “Therapeutic Interchange” should be placed in the order comments
*Note: Convert lower strength to lower strength and higher strength to higher in these cases.
Medications Approved for Automatic Therapeutic Interchange Dosage Conversion Guidelines
(Note: “Therapeutic Interchange” should be placed in the order comments
Medications Approved for Automatic Therapeutic Interchange Dosage Conversion Guidelines
(Note: “Therapeutic Interchange” should be placed in the order comments
Medications Approved for Automatic Therapeutic Interchange Dosage Conversion Guidelines
(Note: “Therapeutic Interchange” should be placed in the order comments